









Markets
/
Stocks
/
nasdaq-aeon
/

Aeon Biopharma Inc

AEON

1.100USD

+0.030+2.80%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

12.81MMarket Cap

0.38P/E TTM



Aeon Biopharma Inc

1.100

+0.030+2.80%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Aeon Biopharma Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2022Q4

FY2022Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

12.15%-2.60M

74.24%-2.09M

8.03%-7.91M

94.36%-621.00K

81.13%-2.96M

---8.12M

---8.60M

-30.34%-11.02M

-35.85%-15.66M

---8.45M

---11.53M

Net income from continuing operations

26.46%-4.54M

-104.05%-6.64M

107.71%9.10M

100.53%2.08M

-115.87%-6.17M

--164.11M

---118.02M

-1029.79%-390.49M

472.38%38.88M

---34.56M

---10.44M

Operating gains losses

-24.00%19.00K

-16.67%20.00K

-24.00%19.00K

-4.17%23.00K

-7.41%25.00K

--24.00K

--25.00K

-25.00%24.00K

107.69%27.00K

--32.00K

--13.00K

Other non-cash items

---37.00K

100.01%16.00K

13.15%72.16M

-100.78%-2.96M

100.00%0.00

---161.23M

--63.77M

1835.53%380.80M

-7329.70%-72.30M

--19.67M

--1.00M

Change in working capital

1.56%-568.00K

125.47%537.00K

-6152.08%-5.81M

327.24%3.29M

87.18%-577.00K

---2.11M

--96.00K

-130.62%-1.45M

-41.72%-4.50M

--4.74M

---3.18M

-Change in prepaid expenses

126.89%338.00K

-85.40%53.00K

-340.32%-298.00K

177.88%257.00K

-249.17%-1.26M

--363.00K

--124.00K

-547.06%-330.00K

-11900.00%-360.00K

---51.00K

---3.00K

Cash from non-recurring investing activities

Cash from operating activities

12.15%-2.60M

74.24%-2.09M

8.03%-7.91M

94.36%-621.00K

81.13%-2.96M

---8.12M

---8.60M

-30.34%-11.02M

-35.85%-15.66M

---8.45M

---11.53M

Investing cash flow

Net cash from continuing investing activities

--0.00

--4.00K

----

--0.00

-100.00%0.00

--9.00K

--228.00K

Capital expenditures

--0.00

--4.00K

----

--0.00

-100.00%0.00

--9.00K

--228.00K

Net cash flow from disposal of fixed assets

--0.00

--4.00K

----

--0.00

-100.00%0.00

--9.00K

--228.00K

Cash from non-current investing activities

Net cash flow from investing activities

--0.00

---4.00K

----

--0.00

100.00%0.00

---9.00K

---228.00K

Financing cash flow

Cash flow from continuous financing activities

68.00%84.00K

-99.16%84.00K

266.92%18.35M

--97.00K

--50.00K

--10.00M

--5.00M

100.00%0.00

-100.00%0.00

---3.99M

--32.50M

Net cash flow from debt Issuance/repayment

----

--0.00

--10.00M

--5.00M

100.00%0.00

-100.00%0.00

---3.99M

--32.50M

Net cash flow from common stock issuance/repurchase

68.00%84.00K

--84.00K

--18.35M

--97.00K

--50.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

68.00%84.00K

-99.16%84.00K

266.92%18.35M

--97.00K

--50.00K

--10.00M

--5.00M

100.00%0.00

-100.00%0.00

---3.99M

--32.50M

Net cash flow

Beginning cash balance

145.18%8.44M

570.47%10.45M

-99.75%13.00K

-97.05%537.00K

-89.83%3.44M

--1.56M

--5.16M

-18.12%18.18M

2219.47%33.84M

--22.20M

--1.46M

Current period cash flow changes

13.53%-2.51M

-206.53%-2.01M

389.81%10.43M

95.24%-524.00K

81.45%-2.91M

--1.88M

---3.60M

11.53%-11.02M

-175.51%-15.66M

---12.46M

--20.74M

Ending cash balance

1003.72%5.93M

145.18%8.44M

570.47%10.45M

-99.82%13.00K

-97.05%537.00K

--3.44M

--1.56M

-26.54%7.16M

-18.12%18.18M

--9.75M

--22.20M

Free cash flow

---2.60M

---2.09M

7.99%-7.91M

----

---8.60M

-30.20%-11.02M

-33.21%-15.66M

---8.46M

---11.76M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

